Ghrelin: The Hunger Hormone Peptide
Medically reviewed by Dr. Sarah Chen, PharmD, BCPS
Ghrelin is a peptide hormone that plays a central role in appetite regulation, earning it the nickname 'the hunger hormone.'
The Role of Ghrelin in Appetite and Hunger
Ghrelin is a 28-amino acid peptide hormone that is primarily produced by the stomach, specifically by enteroendocrine P/D1 cells in the oxyntic glands [1]. It is a key regulator of appetite and food intake and is often referred to as the "hunger hormone." Ghrelin levels rise before meals, stimulating the sensation of hunger, and fall after meals, contributing to the feeling of satiety. This cyclical pattern of ghrelin secretion plays a crucial role in the short-term regulation of food intake. Beyond its role in appetite, ghrelin exists in two main forms: acylated ghrelin (AG), which is the biologically active form, and des-acyl ghrelin (DAG), which is thought to be metabolically inactive but may have other physiological roles [4].
Mechanism of Action
Ghrelin exerts its orexigenic effects by binding to the growth hormone secretagogue receptor (GHSR), a G protein-coupled receptor, predominantly in the arcuate nucleus of the hypothalamus [2]. The activation of GHSR stimulates the release of neuropeptide Y (NPY) and agouti-related peptide (AgRP), two potent appetite-stimulating neuropeptides [5]. These neuropeptides then act on downstream targets to promote food seeking and intake.
Beyond its central effects on appetite, ghrelin also has a wide array of other physiological functions:
Growth Hormone Release: Ghrelin is the only known endogenous ligand for GHSR, making it a potent stimulator of growth hormone (GH) release from the anterior pituitary gland. This action is distinct from its orexigenic effects but highlights its broader endocrine role [6].
Glucose Metabolism: Ghrelin has been implicated in glucose homeostasis, often exhibiting diabetogenic effects by decreasing insulin sensitivity and impairing insulin secretion [7].
Gastrointestinal Motility: Ghrelin can modulate gastrointestinal motility, accelerating gastric emptying and promoting gut contractility [8].
Cardiovascular Effects: Research suggests ghrelin may have cardiovascular protective effects, including vasodilation and anti-inflammatory properties [9].
Neuroprotection: Emerging evidence indicates ghrelin's role in neuroprotection, memory, and mood regulation, suggesting potential therapeutic applications in neurodegenerative diseases [10].
Ghrelin and Obesity
Given its pivotal role in appetite regulation, the ghrelin system has been extensively studied in the context of obesity. Counterintuitively, in individuals with obesity, fasting ghrelin levels are often lower than in lean individuals, and the post-meal suppression of ghrelin is blunted [3]. This suggests that there may be a dysregulation of the ghrelin system in obesity, where the body's compensatory mechanisms might be attempting to reduce hunger signals, yet other factors override this. The blunted post-meal suppression further implies a reduced satiety response, potentially contributing to persistent overeating [11]. However, the precise role of ghrelin in the pathophysiology of obesity is still being investigated, with some theories suggesting that ghrelin resistance or altered sensitivity to ghrelin's effects might be at play in obese individuals.
Therapeutic Targeting of the Ghrelin System
The ghrelin system is an attractive target for the development of anti-obesity drugs due to its direct influence on hunger. Researchers are exploring various strategies to modulate ghrelin signaling:
Ghrelin Receptor Antagonists: These compounds aim to block the binding of ghrelin to GHSR, thereby inhibiting its orexigenic effects. Early studies showed promise in animal models, leading to reduced food intake and body weight [12]. However, translating these findings to humans has been challenging, with issues such as off-target effects and maintaining efficacy without disrupting other vital ghrelin-mediated functions.
Ghrelin Vaccines: This approach involves inducing the production of antibodies that neutralize ghrelin, effectively reducing its circulating levels and preventing it from binding to its receptor. While successful in some animal studies for reducing food intake, the long-term safety and efficacy in humans are still under investigation [13].
Ghrelin Acylation Inhibitors: These compounds aim to prevent the acylation of ghrelin, which is necessary for its biological activity. By inhibiting ghrelin O-acyltransferase (GOAT), the enzyme responsible for acylation, the production of active ghrelin can be reduced [14]. This is a newer area of research with potential for more targeted intervention.
Ghrelin Mimetics (for cachexia): While the focus for obesity is on reducing ghrelin's effects, ghrelin mimetics (GHSR agonists) are being explored for conditions like cachexia (severe weight loss and muscle wasting) and anorexia, where increased appetite and growth hormone release are desirable [15]. Anamorelin, a ghrelin mimetic, has shown promise in increasing appetite and body weight in cancer cachexia patients [16].
However, the development of ghrelin-targeted therapies for obesity has been challenging, and no such drugs have yet been approved for this indication. The complexity of appetite regulation, involving numerous redundant pathways, means that targeting a single hormone like ghrelin may not be sufficient for sustained weight loss.
Ghrelin and Metabolic Health Beyond Obesity
Beyond its direct role in appetite and obesity, ghrelin's influence extends to broader metabolic health, impacting glucose, lipid, and energy metabolism.
Ghrelin's Role in Glucose and Lipid Metabolism
Ghrelin's interaction with glucose metabolism is complex and often viewed as diabetogenic. It tends to increase blood glucose levels through several mechanisms:
Decreased Insulin Secretion: Ghrelin can directly inhibit insulin secretion from pancreatic beta cells, both in vitro and in vivo [7]. This effect is mediated through GHSRs located on pancreatic islets.
Insulin Resistance: Studies suggest that chronic elevation of ghrelin may contribute to insulin resistance in peripheral tissues, reducing glucose uptake by muscle and adipose tissue [17].
Increased Hepatic Glucose Production: Ghrelin may indirectly promote hepatic glucose output, further contributing to hyperglycemia [18].
In terms of lipid metabolism, ghrelin has been shown to promote adipogenesis (fat cell formation) and lipid storage, particularly in visceral fat [19]. This effect, while seemingly counterintuitive given its hunger-stimulating role, suggests ghrelin's adaptive role in energy conservation during periods of caloric scarcity.
Clinical Implications and Future Directions
The multifaceted actions of ghrelin present both challenges and opportunities for therapeutic intervention. For instance, understanding ghrelin's diabetogenic effects is crucial when considering anti-obesity strategies that might inadvertently modulate ghrelin levels. Conversely, ghrelin mimetics could be beneficial in conditions characterized by metabolic dysregulation and energy deficit, such as:
Cachexia: As mentioned, ghrelin mimetics like Anamorelin are being investigated for their ability to increase appetite, body weight, and muscle mass in patients with cancer-related cachexia [16].
Anorexia Nervosa: Given ghrelin's orexigenic effects, targeting the ghrelin system could offer a novel approach to stimulate appetite and promote weight gain in individuals with severe anorexia [20].
Post-Surgical Recovery: Ghrelin's prokinetic effects on the gastrointestinal tract and its ability to stimulate GH release could be beneficial in accelerating recovery after major surgery, particularly in improving gut function and promoting anabolism [8].
The development of highly selective ghrelin receptor modulators that can target specific ghrelin-mediated pathways without affecting others is a key area of ongoing research. This precision could allow for tailored therapies that either suppress appetite for weight loss or stimulate it for weight gain, while minimizing unwanted side effects on glucose metabolism or other systems.
Practical Considerations for Hormone Optimization
While direct ghrelin modulation is primarily a pharmaceutical endeavor, understanding its role can inform broader hormone optimization strategies. Lifestyle interventions that influence ghrelin secretion can be valuable:
Meal Timing and Frequency: Regular meal patterns tend to lead to more predictable ghrelin rhythms. Irregular eating or prolonged fasting can lead to higher baseline ghrelin levels and potentially stronger hunger signals [21].
Diet Composition: Meals rich in protein and fiber tend to induce greater satiety and suppress ghrelin more effectively than high-fat or high-sugar meals [22].
Sleep Quality: Chronic sleep deprivation has been linked to elevated ghrelin levels and reduced leptin (satiety hormone) levels, contributing to increased hunger and caloric intake [23]. Prioritizing adequate sleep is crucial for maintaining healthy ghrelin dynamics.
Stress Management: Chronic stress can disrupt hormonal balance, including ghrelin. Stress-induced eating can be partially mediated by altered ghrelin signaling [24].
Exercise: The impact of exercise on ghrelin is complex and varies with intensity and duration. While acute intense exercise may temporarily suppress ghrelin, regular moderate exercise generally contributes to overall metabolic health and better appetite regulation [25].
| Hormone | Primary Function | Effect on Appetite | Clinical Relevance |
| :------ | :--------------- | :----------------- | :---------------- |
| Ghrelin | Stimulates hunger | Orexigenic | Obesity, Cachexia, Anorexia |
| Leptin | Signals satiety | Anorexigenic | Obesity, Leptin resistance |
| Insulin | Regulates blood sugar | Anorexigenic | Diabetes, Insulin resistance |
| CCK | Stimulates digestion, satiety | Anorexigenic | Post-meal satiety |
| GLP-1 | Enhances insulin secretion, satiety | Anorexigenic | Diabetes, Weight management |
Key Takeaways
Ghrelin is the "hunger hormone" primarily produced by the stomach, existing in active (acylated) and inactive (des-acyl) forms.
It stimulates appetite by binding to GHSR in the hypothalamus, promoting NPY and AgRP release.
Beyond hunger, ghrelin stimulates growth hormone release, influences glucose and lipid metabolism, modulates GI motility, and may have neuroprotective effects.
The ghrelin system is often dysregulated in obesity, with lower fasting ghrelin levels and blunted post-meal suppression, suggesting a complex role in chronic overeating.
Therapeutic targeting of the ghrelin system for obesity includes receptor antagonists, vaccines, and acylation inhibitors, but challenges remain in clinical translation.
Ghrelin mimetics are being explored for conditions like cachexia and anorexia to stimulate appetite and promote weight gain.
Lifestyle factors such as meal timing, diet composition, sleep, and stress management significantly influence ghrelin secretion and overall appetite regulation.
Understanding ghrelin's multifaceted roles is crucial for developing targeted therapies and optimizing metabolic health.
---
References:
[1] Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, A., & Kangawa, K. (1999). Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 402(6762), 656-660.
[2] Cummings, D. E., & Overduin, J. (2007). Ghrelin and hunger: a neuroendocrine perspective. Nature Reviews Neuroscience, 8(10), 719-732.
[3] Tschöp, M., Wawarta, S., Riepl, R. L., Friedrich,
---